X

pharmaceuticals

Johnson & Johnson (JNJ) set to report Q4 earnings. Here’s what to expect

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) will be publishing fourth-quarter results next week. Over the years, the company has…

MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023.…

Earnings Preview: What to look for when UnitedHealth reports Q4 results

Healthcare conglomerate UnitedHealth Group (NYSE: UNH) is preparing to publish fourth-quarter results on Friday. Over the years, the company has…

Earnings Summary: Highlights of DexCom’s Q4 2023 financial results

Healthcare company DexCom, Inc. (NASDAQ: DXCM) announced preliminary results for the fourth quarter of 2023, reporting an estimated double-digit increase…

Walgreens (WBA) to report Q1 results on Thursday. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is scheduled to report first-quarter earnings on Thursday, amid expectations for a mixed outcome.…

Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack…

Johnson & Johnson (JNJ) focuses on innovation after separating consumer business

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical…

Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth

Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite…

Earnings Summary: Highlights of Catalent’s Q1 2024 results

Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for…

Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research…

Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023.…

Gilead Sciences reports Q3 earnings. Here’s everything you need to know

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of…

Gilead Sciences Q3 2023 Earnings: Stay tuned for the live earnings call and real-time transcript

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET.…

VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results

Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The…

Vertex Pharma Q3 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at…

REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase

Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third…

Main highlights from Eli Lilly’s (LLY) Q3 2023 earnings results

Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37%…

Key takeaways from Pfizer’s (PFE) Q3 2023 earnings results

Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter…

AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results

Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023.…

PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results

Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company…

BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also…